Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Acq. announced
Appointed director
Inv. presentation
|
|
Midatech Pharma US Inc. (DARA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/13/2015 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2015 |
SC 13G/A
| ALPHA CAPITAL ANSTALT reports a 5% stake in DARA BIOSCIENCES, INC. |
| 02/19/2014 |
SC 13G/A
| ALPHA CAPITAL ANSTALT reports a 7.7% stake in DARA BIOSCIENCES, INC. |
| 02/12/2014 |
SC 13G/A
| ALPHA CAPITAL ANSTALT reports a 7.7% stake in DARA BIOSCIENCES, INC. |
| 01/29/2014 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 5% stake in Dara Biosciences, Inc. |
| 09/19/2012 |
SC 13G/A
| Honig Barry C reports a 5% stake in DARA BioSciences, Inc. |
| 07/27/2012 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/06/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/12/2008 |
SC 13G/A
| PROQUEST INVESTMENTS LP reports a 0% stake in 1 Point Therapeutics, Inc. |
| 07/10/2007 |
SC 13G/A
| FEDERATED INVESTORS INC reports a 12.8% stake in POINT THERAPEUTICS, INC. |
| 02/13/2007 |
SC 13G/A
| FEDERATED INVESTORS INC reports a 12.8% stake in POINT THERAPEUTICS, INC. |
| 02/14/2006 |
SC 13G/A
| FEDERATED INVESTORS INC reports a 13.3% stake in POINT THERAPEUTICS, INC. |
| 02/14/2006 |
SC 13G/A
| SAC CAPITAL ADVISORS LLC reports a 3.7% stake in Point Therapeutics, Inc. |
| 02/13/2006 |
SC 13G/A
| QVT Financial LP reports a 3.2% stake in Point Therapeutics, Inc. |
| 02/13/2006 |
SC 13G/A
| TANG CAPITAL PARTNERS LP reports a 3% stake in Point Therapeutics, Inc. |
| 04/21/2005 |
SC 13G/A
| BERG MARK STEVEN reports a 4.3% stake in Point Therapeutics, Inc. |
| 02/14/2005 |
SC 13G/A
| FEDERATED INVESTORS INC reports a 10.8% stake in Point Therapeutics, Inc. |
| 02/14/2005 |
SC 13G/A
| SAC CAPITAL ADVISORS LLC reports a 5.5% stake in Point Therapeutics, Inc. |
| 02/11/2005 |
SC 13G/A
| BERG MARK STEVEN reports a 5.1% stake in Point Therapeutics, Inc |
| 12/17/2004 |
SC 13G/A
| LOBELL J JAY reports a 0.8% stake in Point Therapeutics, Inc. |
| 09/10/2004 |
SC 13G/A
| FEDERATED INVESTORS INC reports a 11.1% stake in Point Therapeutics, Inc. |
| 03/31/2004 |
SC 13G/A
| LOBELL J JAY reports a 5.6% stake in Point Therapeutics, Inc. |
| 02/13/2004 |
SC 13G/A
| FEDERATED INVESTORS INC reports a 8.8% stake in Point Therapeutics, Inc. |
| 11/21/2003 |
SC 13G/A
| PROQUEST INVESTMENTS LP reports a 16.7% stake in POINT THERAPEUTICS, INC. |
| 05/05/2003 |
SC 13G/A
| CLAFLIN THOMAS M II reports a 9.7% stake in Point Therapeutics, Inc. |
| 01/10/2001 |
SC 13G/A
| AMVESCAP PLC \GA\ reports a 0% stake in Hemasure, Inc. |
| 03/16/2000 |
SC 13G/A
| SEPRACOR INC reports a 27.4% stake in HEMASURE INC. |
|
|